145 related articles for article (PubMed ID: 11882786)
1. Updated assessment of cystic fibrosis mutation frequencies in non-Hispanic Caucasians.
Palomaki GE; Haddow JE; Bradley LA; FitzSimmons SC
Genet Med; 2002; 4(2):90-4. PubMed ID: 11882786
[TBL] [Abstract][Full Text] [Related]
2. Clinical sensitivity of prenatal screening for cystic fibrosis via CFTR carrier testing in a United States panethnic population.
Palomaki GE; FitzSimmons SC; Haddow JE
Genet Med; 2004; 6(5):405-14. PubMed ID: 15371905
[TBL] [Abstract][Full Text] [Related]
3. Cystic fibrosis testing 8 years on: lessons learned from carrier screening and sequencing analysis.
Strom CM; Crossley B; Buller-Buerkle A; Jarvis M; Quan F; Peng M; Muralidharan K; Pratt V; Redman JB; Sun W
Genet Med; 2011 Feb; 13(2):166-72. PubMed ID: 21068670
[TBL] [Abstract][Full Text] [Related]
4. Cystic fibrosis carrier screening in a North American population.
Zvereff VV; Faruki H; Edwards M; Friedman KJ
Genet Med; 2014 Jul; 16(7):539-46. PubMed ID: 24357848
[TBL] [Abstract][Full Text] [Related]
5. CFTR mutation distribution among U.S. Hispanic and African American individuals: evaluation in cystic fibrosis patient and carrier screening populations.
Sugarman EA; Rohlfs EM; Silverman LM; Allitto BA
Genet Med; 2004; 6(5):392-9. PubMed ID: 15371903
[TBL] [Abstract][Full Text] [Related]
6. The Spectrum of CFTR Variants in Nonwhite Cystic Fibrosis Patients: Implications for Molecular Diagnostic Testing.
Schrijver I; Pique L; Graham S; Pearl M; Cherry A; Kharrazi M
J Mol Diagn; 2016 Jan; 18(1):39-50. PubMed ID: 26708955
[TBL] [Abstract][Full Text] [Related]
7. Cystic fibrosis carrier screening: steps in the development of a mutation panel.
Gilbert F
Genet Test; 2001; 5(3):223-7. PubMed ID: 11788088
[TBL] [Abstract][Full Text] [Related]
8. Analysis of four diverse population groups indicates that a subset of cystic fibrosis mutations occur in common among Caucasians.
Cutting GR; Curristin SM; Nash E; Rosenstein BJ; Lerer I; Abeliovich D; Hill A; Graham C
Am J Hum Genet; 1992 Jun; 50(6):1185-94. PubMed ID: 1376017
[TBL] [Abstract][Full Text] [Related]
9. Racially equitable diagnosis of cystic fibrosis using next-generation DNA sequencing: a case report.
Shum BOV; Bennett G; Navilebasappa A; Kumar RK
BMC Pediatr; 2021 Mar; 21(1):154. PubMed ID: 33789612
[TBL] [Abstract][Full Text] [Related]
10. Is cystic fibrosis carrier screening cost effective?
Wei S; Quigg MH; Monaghan KG
Community Genet; 2007; 10(2):103-9. PubMed ID: 17380060
[TBL] [Abstract][Full Text] [Related]
11. High allelic heterogeneity between Afro-Brazilians and Euro-Brazilians impacts cystic fibrosis genetic testing.
Raskin S; Pereira L; Reis F; Rosario NA; Ludwig N; Valentim L; Phillips JA; Allito B; Heim RA; Sugarman EA; Probst CM; Faucz F; Culpi L
Genet Test; 2003; 7(3):213-8. PubMed ID: 14641997
[TBL] [Abstract][Full Text] [Related]
12. Molecular analysis in Brazilian cystic fibrosis patients reveals five novel mutations.
Bernardino AL; Ferri A; Passos-Bueno MR; Kim CE; Nakaie CM; Gomes CE; Damaceno N; Zatz M
Genet Test; 2000; 4(1):69-74. PubMed ID: 10794365
[TBL] [Abstract][Full Text] [Related]
13. Preconception and prenatal cystic fibrosis carrier screening of African Americans reveals unanticipated frequencies for specific mutations.
Monaghan KG; Bluhm D; Phillips M; Feldman GL
Genet Med; 2004; 6(3):141-4. PubMed ID: 15354332
[TBL] [Abstract][Full Text] [Related]
14. Premarital and prenatal screening for cystic fibrosis: experience in the Ashkenazi Jewish population.
Kornreich R; Ekstein J; Edelmann L; Desnick RJ
Genet Med; 2004; 6(5):415-20. PubMed ID: 15371906
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel and rare mutations in California Hispanic and African American cystic fibrosis patients.
Alper OM; Wong LJ; Young S; Pearl M; Graham S; Sherwin J; Nussbaum E; Nielson D; Platzker A; Davies Z; Lieberthal A; Chin T; Shay G; Hardy K; Kharrazi M
Hum Mutat; 2004 Oct; 24(4):353. PubMed ID: 15365999
[TBL] [Abstract][Full Text] [Related]
16. Improved detection of cystic fibrosis mutations in the heterogeneous U.S. population using an expanded, pan-ethnic mutation panel.
Heim RA; Sugarman EA; Allitto BA
Genet Med; 2001; 3(3):168-76. PubMed ID: 11388756
[TBL] [Abstract][Full Text] [Related]
17. Cystic fibrosis screening using the College panel: platform comparison and lessons learned from the first 20,000 samples.
Strom CM; Huang D; Buller A; Redman J; Crossley B; Anderson B; Entwistle T; Sun W
Genet Med; 2002; 4(4):289-96. PubMed ID: 12172395
[TBL] [Abstract][Full Text] [Related]
18. Cystic fibrosis newborn screening programs: implications of the CFTR variant spectrum in nonwhite patients.
Pique L; Graham S; Pearl M; Kharrazi M; Schrijver I
Genet Med; 2017 Jan; 19(1):36-44. PubMed ID: 27148940
[TBL] [Abstract][Full Text] [Related]
19. A novel mutation detected by temporal temperature gradient gel electrophoresis led to the confirmative prenatal diagnosis of a Hispanic CF family.
Wong LJ; Wang J; Woo M; Hsu E; Bowman CM
Prenat Diagn; 2000 Oct; 20(10):807-10. PubMed ID: 11038458
[TBL] [Abstract][Full Text] [Related]
20. Carrier screening for cystic fibrosis in US genetic testing laboratories: a survey of laboratory directors.
Kaufman DJ; Katsanis SH; Javitt GH; Murphy JA; Scott JA; Hudson KL
Clin Genet; 2008 Oct; 74(4):367-73. PubMed ID: 18700896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
